Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended June 30, 1999
Business Overview: The Company manufactures and distributes nutritional supplements through a direct sales network of independent distributors and managers. Operations are segmented into Domestic (U.S.) and International (Latin America, Asia Pacific, and Other).
Key Financial Metrics
(Amounts in thousands, except per share data)
| Metric | 3 Months Ended June 30, 1999 |
6 Months Ended June 30, 1999 |
|---|---|---|
| Sales Revenue | $71,639 | $143,817 |
| Net Income | $4,796 | $9,786 |
| Operating Income | $7,381 | $15,040 |
| Operating Margin | 10.3% | 10.5% |
| Net Income Margin | 6.7% | 6.8% |
| Cash and Equivalents | $25,468 | $25,468 |
| Short-Term Debt | $1,221 | $1,221 |
| Net Cash from Operations | N/A | $14,782 |
| Diluted EPS | $0.27 | $0.54 |
Material Changes vs. Prior Period
- Revenue Decline: Sales revenue decreased 7.2% for the quarter and 5.7% for the six-month period compared to 1998. Domestic sales fell 6% (quarter) and 4% (six months). International sales fell 10% (quarter) and 9% (six months).
- Profitability: Net income decreased 21.4% for the quarter and 10.8% for the six-month period. Operating income declined 20.0% (quarter) and 11.9% (six months).
- Currency Impact: A significant portion of the international decline is attributed to the devaluation of foreign currencies, specifically the Brazilian real, which devalued approximately 46% against the U.S. dollar in the first half of 1999. Excluding currency effects, international sales would have increased approximately 4%.
- Cost Structure: Cost of goods sold as a percentage of sales improved slightly (17.2% vs 17.7% for the quarter). Volume incentives decreased as a percentage of sales due to a shift in product mix toward items with lower payout rates.
- Cash Flow: Net cash provided by operating activities was $14.78 million for the six months ended June 30, 1999, down from $19.22 million in the prior year period.
Outlook, Risks, and Management Commentary
- Competition: Management cites increased product and price competition in the nutritional supplement market and competition for new distributors as primary drivers for the sales decline. Marketing programs are being tested to restore growth rates.
- Japan Relaunch: The Board authorized $6.0 million for revitalizing operations in Japan, with expenditures expected in the third and fourth quarters of 1999. This investment is expected to impact operating results in those quarters.
- Share Repurchases: The Company repurchased approximately 382,000 shares for $4.5 million during the first six months. A subsequent repurchase of 128,000 shares occurred after June 30, 1999, under a new 500,000 share authorization.
- Liquidity: The Company maintains no credit facility but believes working capital needs can be met via cash and internally generated funds. However, a prolonged economic downturn could adversely affect long-term liquidity.
- Year 2000 (Y2K) Risk: The Company estimates spending $0.5 million to $1.0 million to ensure Y2K compliance. Primary risks involve potential service disruptions from third-party providers (banking, shipping, utilities).
- Legal: The Company is a defendant in various lawsuits, but management believes the outcome will not have a material effect on financial position.
Investor Verification Checklist
- Currency Sensitivity: Verify the extent of exposure to Latin American currencies, particularly the Brazilian real, and the effectiveness of recent price increases in offsetting devaluation.
- Japan Investment ROI: Monitor the $6.0 million Japan relaunch expenditure and its impact on third and fourth-quarter operating margins.
- Distributor Trends: Track the number of active Managers and Distributors to assess the health of the direct sales force amidst increased market competition.
- Y2K Contingency: Confirm the status of third-party vendor compliance and the adequacy of manual backup processes for order processing.
- Debt and Liquidity: Review the Company's ability to fund operations without external credit facilities if sales decline continues or if Y2K remediation costs exceed estimates.